sameAs
Dietary patterns for adults with chronic kidney diseaseHome versus in-centre haemodialysis for end-stage kidney diseaseHMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisTreatment for peritoneal dialysis-associated peritonitisBiocompatible dialysis fluids for peritoneal dialysisHMG CoA reductase inhibitors (statins) for dialysis patientsInterventions for erythropoietin-resistant anaemia in dialysis patientsHMG CoA reductase inhibitors (statins) for kidney transplant recipientsHome versus in-centre haemodialysis for end-stage kidney diseaseInterventions for treating sexual dysfunction in patients with chronic kidney diseaseHMG CoA reductase inhibitors (statins) for dialysis patientsBiocompatible dialysis fluids for peritoneal dialysisHMG CoA reductase inhibitors (statins) for kidney transplant recipientsHMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisHMG CoA reductase inhibitors (statins) for dialysis patientsInterventions for erythropoietin-resistant anaemia in dialysis patientsHMG CoA reductase inhibitors (statins) for kidney transplant recipientsCatheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patientsAntimicrobial agents for preventing peritonitis in peritoneal dialysis patientsPrevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studiesDietary interventions for adults with chronic kidney diseaseAntimicrobial agents for preventing peritonitis in peritoneal dialysis patientsChanges in the worldwide epidemiology of peritoneal dialysis.The Current State of Peritoneal DialysisThe Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis.Fall-related risk factors and osteoporosis in women with rheumatoid arthritis.Clinician beliefs and attitudes about home haemodialysis: a multinational interview study.The beliefs and expectations of patients and caregivers about home haemodialysis: an interview study.Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: a multicenter registry studyEffects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsIs the declining use of long-term peritoneal dialysis justified by outcome data?Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial.Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders.Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients.Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases.Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.
P50
Q24187446-B86A5874-4114-4798-A968-E950D6DD0148Q24187895-EB58B7A5-D863-4529-B04E-E8777DE9E630Q24194514-FF5AA6C2-922E-4774-B3E8-CE630DB07E5CQ24195002-ED8EDE3E-70EF-42B4-8F59-D3438578D6FBQ24197836-DBB61461-C709-4A41-AD08-F7B55125DD61Q24198108-E1384B0A-6BB5-49E8-BDD2-6E1057CD3992Q24200248-5C1A8E8E-C3CA-4411-A9A3-F994B4B6D556Q24200984-25193E18-F01D-4746-923C-C2B16B390E1CQ24203971-0001F5CA-3B3C-42C5-A88E-70C114776EF7Q24235471-912B0CD4-C34D-4306-8E9E-C9C7CE691012Q24239881-411F4096-2765-4BAF-AF6E-C6639E9A981FQ24240521-F09ABB86-0902-46BF-8203-6A790E3B1ED9Q24241098-1C299EE0-12DD-4DD0-BAB1-CE0095DD70D8Q24241472-719B265A-FA51-4524-8402-1ED00CC09ECCQ24241531-662D2B0C-FFCD-4904-B085-7A39805B13C5Q24241704-446A9977-2A7E-4698-85C6-D7DA67F9D7C3Q24242586-88AF2110-2C34-4825-8B45-CFC6E640947AQ24245875-F00FC30B-ED3B-4F71-92B9-6613B83269CCQ24246043-F221ADC1-4C8C-4A9A-9888-1A4ACDAECAB6Q26822863-74EA6322-BD62-4133-99AB-9104E0D8AB81Q29994576-9996582F-5363-4ECB-B329-C468D1EBBA0AQ29994654-5B63BFD8-68F1-4963-9D7D-D6D6538C301EQ30239926-FB8C11A4-23B0-4741-BF19-C1F6552DBB32Q30243902-874C9B12-EEBD-4E50-BA36-6EF6CDC1190DQ30251447-0905FDA2-936F-4469-94AD-5858650C195DQ30482694-94B05AED-6E98-4276-9321-A8A5DE4ACB62Q30530824-57D5005B-B685-4C7C-933D-A1878B577874Q30534293-B297CB03-25AA-471A-B7D1-9E50BC50CF8FQ30560814-0EBB1B6B-1DD9-4E5F-B493-7259C7229B2CQ30841365-E14C43AD-2CA4-4371-A18A-3114A3607BA4Q31133382-2FC4C386-C290-43C8-8667-72A2E3C326BCQ31965305-6B2155C1-5290-461D-899E-F7765A8C2D62Q33356816-32985401-381E-4144-9794-90BF3D992385Q33394541-372A09E9-7E4E-4751-955A-98BF0DDD1503Q33404656-606E0E62-2A28-4D60-85ED-33ACB779305EQ33432770-9EBAA66D-AD51-4010-A1DC-8EB6F5A222FAQ33461866-BD97FDC0-9190-42AC-8954-B3CD20663F21Q33486767-DE87BCB3-1B0A-4920-AC4D-468322CE3C8BQ33487493-741D5147-25D8-4D49-A421-88B8EB125FA7Q33494980-936CB8B1-6D64-4002-A6C5-25D4861D4CC8
P50
description
hulumtues
@sq
nephrologist
@en
wetenschapper
@nl
հետազոտող
@hy
name
David W Johnson
@ast
David W Johnson
@es
David W Johnson
@nl
David W Johnson
@sl
David W. Johnson
@en
ডেভিড জনসন
@bn
type
label
David W Johnson
@ast
David W Johnson
@es
David W Johnson
@nl
David W Johnson
@sl
David W. Johnson
@en
ডেভিড জনসন
@bn
altLabel
David Johnson
@ast
David Johnson
@en
David Johnson
@es
David W Johnson
@en
prefLabel
David W Johnson
@ast
David W Johnson
@es
David W Johnson
@nl
David W Johnson
@sl
David W. Johnson
@en
ডেভিড জনসন
@bn
P1053
F-2897-2011
P106
P1960
Js4hHgYAAAAJ
P2038
David_Johnson25
P21
P31
P3829
P496
0000-0001-5491-3460
P551
P569
1964-01-01T00:00:00Z